Arcane

Arcane is a biotechnology company developing a "health operating system" centered on its proprietary Elastin-Like Polypeptides (ELP) platform. These programmable biopolymers act as non-invasive delivery vehicles for therapeutic payloads, including gene sequences and proteins, aiming to reprogram cellular behavior and restore biological instructions without the need for injections or viral vectors. The company's diverse pipeline includes consumer-facing regenerative skincare and hair restoration products, as well as clinical-grade therapeutics for metabolic health, oncology, and chronic diseases such as Multiple Sclerosis and Type 1 Diabetes. Arcane operates with a dual-track commercialization strategy, leveraging its modular platform to generate near-term revenue while advancing high-value pharmaceutical assets.